|MyoKardia Inc -- USA Stock|| |
USD 36.6 0.35 0.95%
Co-FounderWe currently do not have informatin regarding Leslie Leinwand. This executive tanure with MyoKardia Inc is not currenlty determined.
The company has return on total asset (ROA)
of (9.55) %
which means that it has lost $9.55 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (19.24) %
meaning that it created substantial loss on money invested by shareholders.
MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia Inc (MYOK) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 77 people. MyoKardia is listed under Pharmaceutical Products category by Fama And French industry classification.